Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor

被引:241
|
作者
AbuAmer, Y [1 ]
Ross, FP [1 ]
Edwards, J [1 ]
Teitelbaum, SL [1 ]
机构
[1] WASHINGTON UNIV, SCH MED, DEPT PATHOL, BARNES JEWISH HOSP N, ST LOUIS, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1997年 / 100卷 / 06期
关键词
bone resorption; periodontitis; tumor necrosis factor receptor; thalidomide; bone marrow macrophages;
D O I
10.1172/JCI119679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic bone infection, as attends periodontitis, is often complicated by severe osteolysis. While LPS is believed to be central to the pathogenesis of the osteolytic lesion, the mechanisms by which this bacteria-derived molecule promotes bone resorption are unknown. We find that LPS induces bone marrow macrophages (BMMs) to express c-src, a protooncogene product that we demonstrate is a specific marker of commitment to the osteoclast phenotype. We next turned to possible soluble mediators of LPS-induced c-src. Of a number of osteoclastogenic cytokines tested, only TNF-alpha mirrors the c-src-enhancing effect of LPS. Suggesting that LPS augmentation of c-src is TNF-mediated, endotoxin sequentially induces BMM expression of TNF, followed by c-src. TNF and c-src expression, by cultured BMMs derived from LPS-injected mice, reflects duration of exposure to circulating endotoxin, intimating that endotoxin's effect in vivo is also mediated by TNF, Consistent with these findings, thalidomide (which antagonizes TNF action) attenuates c-src induction by LPS, An anti-TNF antibody blacks LPS enhancement of c-src mRNA, validating the cytokine's modulating role in vitro, Using BMMs of TNF receptor-deleted mice, we demonstrate that TNF induction of c-src is transmitted through the cytokine's p55, but not p75, receptor. Most importantly, LPS administered to wild-type mice prompts osteoclast precursor differentiation, manifest by profound osteoclastogenesis in marrow cultured ex vivo, and by a profusion of marrow-residing cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo, In contrast, LPS does not substantially enhance osteoclast proliferation in mice lacking the p55TNF receptor, confirming that LPS-induced osteoclastogenesis is mediated by TNF in vivo via this receptor, Thus, therapy targeting TNF and/or its p55 receptor presents itself as a means of preventing the osteolysis of chronic bacterial infection.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
  • [31] TUMOR-NECROSIS-FACTOR INDUCES LIPOPOLYSACCHARIDE TOLERANCE IN A HUMAN ADENOCARCINOMA CELL-LINE MAINLY THROUGH THE TNF P55 RECEPTOR
    LAEGREID, A
    THOMMESEN, L
    JAHR, TG
    SUNDAN, A
    ESPEVIK, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) : 25418 - 25425
  • [32] TUMOR-NECROSIS-FACTOR RELEASE FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN MONOCYTES - LIPOPOLYSACCHARIDE TOLERANCE INVITRO
    MATIC, M
    SIMON, SR
    CYTOKINE, 1991, 3 (06) : 576 - 583
  • [33] Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection
    Zhao, YX
    Zhang, HW
    Chiu, B
    Payne, U
    Inman, RD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1662 - 1672
  • [34] Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis
    Gonzalez-Calvin, JL
    Gallego-Rojo, F
    Fernandez-Perez, R
    Casado-Caballero, F
    Ruiz-Escolano, E
    Olivares, EG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4325 - 4330
  • [35] Tumor necrosis factor-α and its receptors, p55 and p75, in gingiva of adult periodontitis
    Tervahartiala, T
    Koski, H
    Xu, JW
    Häyrinen-Immonen, R
    Hietanen, J
    Sorsa, T
    Konttinen, YT
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (06) : 1535 - 1539
  • [36] UNILAMELLAR LIPOSOMES MODULATE SECRETION OF TUMOR-NECROSIS-FACTOR BY LIPOPOLYSACCHARIDE-STIMULATED MACROPHAGES
    BRISSEAU, GF
    KRESTA, A
    SCHOUTEN, D
    BOHNEN, JMA
    SHEK, PN
    FOK, E
    ROTSTEIN, OD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) : 2671 - 2675
  • [37] TUMOR NECROSIS FACTORS CYTOTOXIC ACTIVITY IS SIGNALED BY THE P55 TNF RECEPTOR
    TARTAGLIA, LA
    ROTHE, M
    HU, YF
    GOEDDEL, DV
    CELL, 1993, 73 (02) : 213 - 216
  • [38] Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages
    Jeong, JY
    Jue, DM
    JOURNAL OF IMMUNOLOGY, 1997, 158 (10): : 4901 - 4907
  • [39] Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor IgG fusion protein
    Corcoran, AE
    Scallon, BJ
    Trinh, H
    Chernajovsky, Y
    Ghrayeb, J
    Feldmann, M
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 255 - 262
  • [40] CYTOPLASMIC TRUNCATION OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR ABOLISHES SIGNALING, BUT NOT INDUCED SHEDDING OF THE RECEPTOR
    BRAKEBUSCH, C
    NOPHAR, Y
    KEMPER, O
    ENGELMANN, H
    WALLACH, D
    EMBO JOURNAL, 1992, 11 (03): : 943 - 950